Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082888
Status:
COMPLETED
Last Update Posted:
2020-04-13
First Post:
2004-05-14
Brief Title:
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2004-05-14
First Submit QC Date:
May 18 2004
Study First Post Date:
2004-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-12-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-03
Last Update Post Date:
2020-04-13
Last Update Post Date Type:
ACTUAL